3-hydroxyphencyclidine has been researched along with naloxonazine in 1 studies
| Studies (3-hydroxyphencyclidine) | Trials (3-hydroxyphencyclidine) | Recent Studies (post-2010) (3-hydroxyphencyclidine) | Studies (naloxonazine) | Trials (naloxonazine) | Recent Studies (post-2010) (naloxonazine) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 200 | 0 | 30 |
| Protein | Taxonomy | 3-hydroxyphencyclidine (IC50) | naloxonazine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0072 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.136 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.085 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itzhak, Y; Johnson, N; Pasternak, GW | 1 |
1 other study(ies) available for 3-hydroxyphencyclidine and naloxonazine
| Article | Year |
|---|---|
Interaction of two phencyclidine opiate-like derivatives with 3H-opioid binding sites.
Topics: Analgesics; Animals; Binding, Competitive; Dihydromorphine; Male; Naloxone; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu | 1984 |